A WTKR-News 3 story from northeastern North Carolina reports that UNC has begun enrolling participants for the Novavax COVID-19 vaccine phase III trial.
Cindy Gay, MD, associate professor in the division of infectious diseases, describes the need for a diverse participation for the trial, including people over the age of 65, Black and Latino communities, and people living with medical conditions.
Read the article here.